Shifting Paradigms in the Treatment of Systemic Lupus Erythematosus
Canadian Rheumatology Today · 2024
DOI: 10.58931/crt.2024.1248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Rheumatology Today, 2024. Verfasst von Ann E. Clarke und 4 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
For many years, therapeutic options for patients with systemic lupus erythematosus (SLE) have been extremely limited. However, over the past decade, with the approval of new drugs and several promising phase II trials, treatment paradigms are gradually shifting toward multi‑targeted therapies for lupus nephritis (LN) and earlier usage of biologics in extra-renal lupus. Below, we will present three patient cases that illustrate how, through a multidisciplinary clinic environment, we have incorporated these shifting treatment paradigms into our delivery of care. Finally, we will conclude with a discussion of emerging therapies, which have the potential to further shift, and ultimately transform, treatment paradigms.
Zitieren
APA
Clarke, A. E., Barber, M. R., Barr, B., Cheema, K., & Li, I. L. (2024). Shifting Paradigms in the Treatment of Systemic Lupus Erythematosus. Canadian Rheumatology Today. https://doi.org/10.58931/crt.2024.1248
Vancouver
Clarke AE, Barber MR, Barr B, Cheema K, Li IL. Shifting Paradigms in the Treatment of Systemic Lupus Erythematosus. Canadian Rheumatology Today. 2024. doi:10.58931/crt.2024.1248
BibTeX
@article{Clarke2024,
author = {Clarke, Ann E. and Barber, Megan R.W. and Barr, Bryce and Cheema, Kim and Li, Icholas L.},
title = {Shifting Paradigms in the Treatment of Systemic Lupus Erythematosus},
journal = {Canadian Rheumatology Today},
year = {2024},
doi = {10.58931/crt.2024.1248}
}
EUVIMED